Dr. Hendel Back Pain Relief Tablet
NDC Package 62795-1114-2
Package Information
Dr. Hendel Back Pain Relief (horse chestnut, bryonia alba root, citrullus colocynthis fruit pulp, solanum dulcamara top, pseudognaphalium obtusifolium, hypericum perforatum, strychnos nux-vomica seed, and toxicodendron pubescens leaf) tablets is back Pain Relief. This formulation utilizes a tablet delivery system. Marketed by Medinatura Inc, this product is identified by NDC 62795-1114.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 62795 - Medinatura Inc
- 62795-1114 - Dr. Hendel Back Pain Relief
- 62795-1114-2 - 100 TABLET in 1 BOTTLE
- 62795-1114 - Dr. Hendel Back Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62795-1114-2 identifies a specific commercial package of 100 tablet in 1 bottle of Dr. Hendel Back Pain Relief, a human over the counter drug labeled by Medinatura Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains bryonia alba root; citrullus colocynthis fruit pulp; horse chestnut; hypericum perforatum; pseudognaphalium obtusifolium; solanum dulcamara top; strychnos nux-vomica seed; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medinatura Inc on August 01, 2016.
How is this Medinatura Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62795111402. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.